Negar Karimian1,2, Petru Niculiseanu1, Alexandre Amar-Zifkin3, Francesco Carli4, Liane S Feldman5,6,7,8. 1. Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University Health Centre, Montreal, QC, Canada. 2. Division of Experimental Surgery, McGill University, Montreal, QC, Canada. 3. McGill University Health Centre Libraries, Montreal, QC, Canada. 4. Department of Anesthesia, McGill University, Montreal, QC, Canada. 5. Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University Health Centre, Montreal, QC, Canada. liane.feldman@mcgill.ca. 6. Division of Experimental Surgery, McGill University, Montreal, QC, Canada. liane.feldman@mcgill.ca. 7. Department of Surgery, McGill University, Montreal, QC, Canada. liane.feldman@mcgill.ca. 8. Montreal General Hospital, 1650 Cedar Ave, L9-404, Montreal, QC, H3G 1A4, Canada. liane.feldman@mcgill.ca.
Abstract
IMPORTANCE: Pre-operative hyperglycemia is associated with post-operative adverse outcomes in diabetic and non-diabetic patients. Current pre-operative screening includes random plasma glucose, yet plasma glycated hemoglobin (HbA1c) is a better measure of long-term glycemic control. It is not clear whether pre-operative HbA1c can identify non-diabetic patients at risk of post-operative complications. OBJECTIVE: The systematic review summarizes the evidence pertaining to the association of suboptimal pre-operative HbA1c on post-operative outcomes in adult surgical patients with no history of diabetes mellitus. EVIDENCE REVIEW: A detailed search strategy was developed by a librarian to identify all the relevant studies to date from the major online databases. FINDINGS: Six observational studies met all the eligibility criteria and were included in the review. Four studies reported a significant association between pre-operative HbA1c levels and post-operative complications in non-diabetic patients. Two studies reported increased post-operative infection rates, and two reported no difference. Of four studies assessing the length of stay, three did not observe any association with HbA1c level and only one study observed a significant impact. Only one study found higher mortality rates in patients with suboptimal HbA1c. CONCLUSIONS AND RELEVANCE: Based on the limited available evidence, suboptimal pre-operative HbA1c levels in patients with no prior history of diabetes predict post-operative complications and represent a potentially modifiable risk factor.
IMPORTANCE: Pre-operative hyperglycemia is associated with post-operative adverse outcomes in diabetic and non-diabeticpatients. Current pre-operative screening includes random plasma glucose, yet plasma glycated hemoglobin (HbA1c) is a better measure of long-term glycemic control. It is not clear whether pre-operative HbA1c can identify non-diabeticpatients at risk of post-operative complications. OBJECTIVE: The systematic review summarizes the evidence pertaining to the association of suboptimal pre-operative HbA1c on post-operative outcomes in adult surgical patients with no history of diabetes mellitus. EVIDENCE REVIEW: A detailed search strategy was developed by a librarian to identify all the relevant studies to date from the major online databases. FINDINGS: Six observational studies met all the eligibility criteria and were included in the review. Four studies reported a significant association between pre-operative HbA1c levels and post-operative complications in non-diabeticpatients. Two studies reported increased post-operative infection rates, and two reported no difference. Of four studies assessing the length of stay, three did not observe any association with HbA1c level and only one study observed a significant impact. Only one study found higher mortality rates in patients with suboptimal HbA1c. CONCLUSIONS AND RELEVANCE: Based on the limited available evidence, suboptimal pre-operative HbA1c levels in patients with no prior history of diabetes predict post-operative complications and represent a potentially modifiable risk factor.
Authors: K Dhatariya; N Levy; A Kilvert; B Watson; D Cousins; D Flanagan; L Hilton; C Jairam; K Leyden; A Lipp; D Lobo; M Sinclair-Hammersley; G Rayman Journal: Diabet Med Date: 2012-04 Impact factor: 4.359
Authors: Richard Merchant; Daniel Chartrand; Steven Dain; Gregory Dobson; Matt M Kurrek; Annie Lagacé; Shean Stacey; Barton Thiessen Journal: Can J Anaesth Date: 2015-01 Impact factor: 5.063
Authors: Sathish Mohan; Christodoulos Kaoutzanis; Kathleen B Welch; James F Vandewarker; Suzanne Winter; Greta Krapohl; Richard M Lampman; Michael G Franz; Robert K Cleary Journal: Int J Colorectal Dis Date: 2015-07-23 Impact factor: 2.571
Authors: Milo Engoren; Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir Shah Journal: J Cardiothorac Surg Date: 2008-11-24 Impact factor: 1.637
Authors: Roma Y Gianchandani; Sima Saberi; Preethi Patil; Richard L Prager; Rodica Pop-Busui Journal: Front Endocrinol (Lausanne) Date: 2015-08-11 Impact factor: 5.555
Authors: Mazen R Al-Mansour; Melanie Vargas; Molly A Olson; Anand Gupta; Thomas E Read; Nelson N Algarra Journal: Surg Endosc Date: 2022-08-15 Impact factor: 3.453
Authors: Floris van Raalten; Yasmine L Hiemstra; Noor Keulen; Yoni van Duivenvoorde; Katrin Stoecklein; Evert A Verhagen; Christa Boer Journal: J Clin Monit Comput Date: 2019-01-18 Impact factor: 2.502
Authors: Richard H Parrish; Heather Monk Bodenstab; Dustin Carneal; Ryan M Cassity; William E Dager; Sara J Hyland; Jenna K Lovely; Alyssa Pollock; Tracy M Sparkes; Siu-Fun Wong Journal: J Clin Med Date: 2022-09-24 Impact factor: 4.964
Authors: Chelsia Gillis; Leslee Hasil; Popi Kasvis; Neil Bibby; Sarah J Davies; Carla M Prado; Malcolm A West; Clare Shaw Journal: Front Nutr Date: 2021-06-24
Authors: Lisa D Yee; Joanne E Mortimer; Rama Natarajan; Eric C Dietze; Victoria L Seewaldt Journal: Front Endocrinol (Lausanne) Date: 2020-02-20 Impact factor: 5.555